Neonova by Epigones Group - NPS Pharmaceuticals Announces Completion of Patient Randomization in Phase 3 STEPS Study of GATTEX®

Home
Contact Us

Newsflash

Neonova - the software program offered by Abbott Nutrition to meet the special needs of healthcare professionals who clinically manage the nutritional care of premature infants.

NOTE: Product only available for Canadian customers.

News on Pediatric Nutrition
Researchers identify new neurological deficit behind lazy eye Tween boys tackle obesity: One family's story S-P-E-L-L-I-N-G at S-T-R-O-N-G-S-V-I-L-L-E :Macy's and Reading is Fundamental team for fifth annual Cachexia reduces function and changes muscle structure of heart in mice with colon cancer Haitian toddler 'makes all of us smile' Fight weight gain at college with a plan Your Space: Getting the 'perfect body' or giving into media fads? Focus: Childhood Obesity Young patients, adult condition HealthKey: Inflammatory bowel disease on the rise in children HealthKey: Inflammatory bowel disease on the rise in kids Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the Virginia Commonwealth University experts available to discuss childhood obesity Childhood Obesity Awareness Month 'Makes all of us smile'

News on Pediatric Nutrition

Researchers identify new neurological deficit behind lazy eye
Tween boys tackle obesity: One family's story
S-P-E-L-L-I-N-G at S-T-R-O-N-G-S-V-I-L-L-E :Macy's and Reading is Fundamental team for fifth annual
Cachexia reduces function and changes muscle structure of heart in mice with colon cancer
Haitian toddler 'makes all of us smile'
Fight weight gain at college with a plan
Your Space: Getting the 'perfect body' or giving into media fads?
Focus: Childhood Obesity
Young patients, adult condition
HealthKey: Inflammatory bowel disease on the rise in children
HealthKey: Inflammatory bowel disease on the rise in kids
Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the
Virginia Commonwealth University experts available to discuss childhood obesity
Childhood Obesity Awareness Month
'Makes all of us smile'

NPS Pharmaceuticals Announces Completion of Patient Randomization in Phase 3 STEPS Study of GATTEX®

Thursday, 22 July 2010
BEDMINSTER, N.J.----NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase 3 registration study of GATTEX® . Find more about it here. Copyright © 2010. All rights reserved. Yahoo! News News provided by GreenIvory MashupXFeed.

< Prev		Next >

[ Back ]

Main Menu

Home

Recent Documentation

Documentation and Support